Welcome to our dedicated page for Phreesia news (Ticker: PHR), a resource for investors and traders seeking the latest updates and insights on Phreesia stock.
Phreesia, Inc. (NYSE: PHR) is a healthcare technology company focused on patient activation, digital intake, outreach and education for healthcare providers, life sciences companies and other organizations. The Phreesia news feed on Stock Titan highlights company announcements, financial updates and product developments that shape how it engages patients and supports healthcare workflows.
Investors and industry followers can use this page to review earnings releases and outlook updates, where Phreesia reports quarterly revenue, subscription and related services, payment processing fees, network solutions revenue and key metrics such as average healthcare services clients and revenue per client. These updates often include management commentary on operating leverage, cash flows and non-GAAP measures like Adjusted EBITDA.
The news stream also features transaction and financing disclosures, including details about the acquisition of AccessOne Parent Holdings, Inc., a provider of financing solutions for healthcare receivables, and related bridge loan and credit facility arrangements. These items are relevant for understanding Phreesia’s growth strategy and capital structure.
In addition, readers will find product and innovation news, such as the launch of Phreesia VoiceAI, an AI-driven phone solution for managing patient calls, and partnership and recognition stories, including the collaboration with Sesame Workshop and inclusion in rankings like the Deloitte Technology Fast 500™ and Capterra Shortlists. Bookmark this page to follow how Phreesia communicates its performance, platform enhancements and strategic initiatives over time.
Phreesia (NYSE: PHR) was named one of The Software Report’s Top 50 Software Companies of 2025 on December 18, 2025. This is the fourth consecutive year Phreesia made the list and the first time it ranked in the Top 10. The award cites product excellence, organizational strength, culture, growth, and management caliber.
In 2025 Phreesia introduced Phreesia VoiceAI, a conversational automation tool for healthcare phone calls, which the company said supports its goal of making care easier for patients and providers.
Phreesia (NYSE: PHR) reported fiscal Q3 2026 results for the quarter ended October 31, 2025: total revenue $120.3M (+13% YoY), AHSCs 4,520 (+7% YoY), and revenue per AHSC $26,622 (+6% YoY). Net income was $4.3M versus a net loss of $14.4M year-ago; Adjusted EBITDA $29.1M versus $9.8M year-ago. Cash and cash equivalents were $106.4M as of October 31, 2025.
Post-quarter, Phreesia completed the AccessOne acquisition for approximately $160M on November 12, 2025, funded in part by a $110M 364-day bridge loan. Fiscal 2026 outlook was updated to $479M–$481M revenue and $99M–$101M Adjusted EBITDA. Fiscal 2027 outlook introduced: $545M–$559M revenue (14–16% growth) and $125M–$135M Adjusted EBITDA; AccessOne is expected to represent ~6.5% of fiscal 2027 revenue.
Phreesia (NYSE: PHR) announced that Megan Turco, Director of Client Experience for Phreesia Network Solutions, was named to MM+M’s 2025 40 Under 40. Since joining in 2018, Turco advanced through five roles and scaled the Client Experience team from four people to more than 50. She leads a sales organization servicing 80+ life sciences and agency clients and has overseen programs that reached millions of patients.
The team exceeded targets for four consecutive years with double‑digit annual revenue growth, and internal surveys show 95% client ratings of very good/excellent and 94% reporting great service.
Phreesia (NASDAQ: PHR) was named to the 2025 Deloitte Technology Fast 500, which ranks the 500 fastest-growing tech, media, telecom, life sciences, fintech and energy tech companies in North America based on fiscal year revenue growth from 2021 to 2024. Phreesia said this is its first Fast 500 appearance and credited the recognition to team performance and its mission to simplify care. The release notes eligibility criteria for the list, including base-year revenues of at least $50,000, current-year revenues of at least $5 million, and a minimum four-year operating history. Phreesia reported it enabled approximately 170 million patient visits in 2024 (about 1 in 7 U.S. visits).
Phreesia (NYSE: PHR) will release its fiscal third quarter 2026 results after market close on Monday, Dec. 8, 2025. The company will post a press release and a quarterly stakeholder letter on its investor website at ir.phreesia.com.
Phreesia will host a live conference call and webcast on Dec. 8, 2025 at 5:00 PM Eastern; dial-in numbers and conference code are provided on the investor events page. A replay will be available on the same web link for approximately 90 days.
About Phreesia: a patient-activation platform that enabled approximately 170 million patient visits in 2024, serving healthcare providers and life sciences customers. For investor or media inquiries, contact details are listed on the company site.
Phreesia (NYSE: PHR) was named to the 2025 Capterra Shortlists in the Appointment Reminder and Appointment Scheduling categories on October 8, 2025.
This marks Phreesia's third and fourth shortlist placements in 2025 after earlier inclusion for Patient Engagement and Medical Scheduling. Phreesia reported an overall 4.3/5 rating on Capterra, and highlighted user feedback on reduced no-shows and fewer scheduling calls. The company said its digital tools support provider scheduling, patient engagement and outreach.
Founded in 2005, Phreesia enabled approximately 170 million patient visits in 2024, and provides patient intake and digital engagement solutions for healthcare organizations.
Phreesia (NYSE:PHR), a leading patient intake and activation platform, has been recognized on TIME's inaugural World's Top HealthTech Companies of 2025 list. The company received a 'very high' performance indicator in the Health Information & Management category. Phreesia's platform facilitated 170 million patient visits in 2024, representing approximately 1 in 7 healthcare visits across the United States.
The TIME recognition, developed in partnership with Statista, evaluates companies based on financial performance, reputation analysis, and online engagement across six market segments. Phreesia's digital solutions focus on patient intake, outreach, education, and activation, aiming to enhance patient experience and improve healthcare outcomes.
["Recognition as a top healthtech company by TIME magazine", "Platform handles 1 in 7 healthcare visits in the U.S.", "Significant scale with 170 million annual patient visits"]Phreesia (NYSE:PHR), a leading patient intake and activation platform, announced that Sara DiNardo, Vice President of Client Solutions, has been named to Becker's Hospital Review's 2025 Rising Stars: 100 Healthcare Leaders Under 40 list.
DiNardo oversees Phreesia's client-facing teams, focusing on implementing digital tools for healthcare organizations to improve efficiency and patient engagement. During her 10-year tenure at Phreesia, she has become instrumental in helping healthcare clients navigate operational challenges. The company notably facilitated approximately 170 million patient visits in 2024, representing 1 in 7 visits across the United States.
Phreesia (NYSE: PHR) reported strong Q2 fiscal 2026 results, marking its first-ever net income positive quarter. The company achieved total revenue of $117.3 million, up 15% year-over-year, with 4,467 healthcare services clients. Key financial highlights include net income of $0.7 million, compared to a $18.0 million loss last year, and Adjusted EBITDA of $22.1 million, up from $6.5 million.
Phreesia announced a definitive agreement to acquire AccessOne, a healthcare receivables financing solutions provider, expected to close in Q3 or early Q4 FY2026. The company maintained its FY2026 revenue outlook of $472-482 million and raised its Adjusted EBITDA guidance to $87-92 million. The acquisition will be financed through cash and a bridge loan.
Phreesia (NYSE: PHR) has announced a definitive agreement to acquire AccessOne for $160 million in cash. AccessOne, a portfolio company of Frontier Growth, is a market leader in healthcare receivables financing solutions, managing a portfolio of approximately $450 million.
The transaction is expected to close during Q3 or early Q4 of Phreesia's fiscal year 2026. The acquisition will be financed through a combination of cash and a new bridge loan. Phreesia anticipates the acquisition to contribute approximately $35 million in annualized revenue and $11 million in annualized Adjusted EBITDA.
AccessOne's platform provides healthcare providers with scalable, compliant tools for improving collections while maintaining patient trust. The acquisition aligns with Phreesia's mission of making healthcare more accessible and is expected to expand their addressable market.
FAQ
What is the current stock price of Phreesia (PHR)?
What is the market cap of Phreesia (PHR)?
